Table 5.
Current study | Chen et al[20] | Chow et al[21] | Faubion et al[25] | Tung et al[26] | Jeon et al[22] | Ho et al[17] | |
Area | Mainland China | Guangzhou | Hong Kong | Olmsted | Olmsted | Korea | UK |
(China) | (China) | (USA) | (USA) | ||||
Cases, n | 101 | 81 | 95 | 63 | 14 (≤ 19 yr) | 67.0 | 86 |
Date | 2007-2011 | 2002-2010 | 1985-2007 | 1970-1993 | 1940-2001 | 1996-2010 | 1998-2003 |
Study type | Multi-center | Single-center | Single-center | Population-based | Population-based | Single-center | Single-center |
Within 1 mo, % | |||||||
Response | 95 | 97.5 | 93.7 | 84 | 79 | 78.5 | 82 |
Non-response | 5 | 2.5 | 6.3 | 16 | 21 | 19.7 | 25 |
Within 1 yr, % | |||||||
Pronged response | 41.6 | 67.1 | 46.3 | 49 | 57 | 46.3 | 55 |
CS dependence | 49.5 | 32.9 | 47.4 | 22 | 14 | 42.6 | 17 |
Surgery | 6.9 | 0 | 7.4 | 29 | 29 | 16.0 | 21 |
Part of the cases had previous use of corticosteroids. Different studies were conducted in different areas, dates and cohorts to evaluate corticosteroid response in ulcerative colitis according to the similar classification of corticosteroid response. CS: Corticosteroid.